NO910331D0 - Rekombinant plasmid, fremgangsmaate til dets fremstilling og anvendelse av plasmidet i produksjonen av proteiner. - Google Patents

Rekombinant plasmid, fremgangsmaate til dets fremstilling og anvendelse av plasmidet i produksjonen av proteiner.

Info

Publication number
NO910331D0
NO910331D0 NO910331A NO910331A NO910331D0 NO 910331 D0 NO910331 D0 NO 910331D0 NO 910331 A NO910331 A NO 910331A NO 910331 A NO910331 A NO 910331A NO 910331 D0 NO910331 D0 NO 910331D0
Authority
NO
Norway
Prior art keywords
plasmid
proteins
procedure
preparation
production
Prior art date
Application number
NO910331A
Other languages
English (en)
Other versions
NO910331L (no
Inventor
Walter Bodemer
Friedrich Scheiflinger
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of NO910331D0 publication Critical patent/NO910331D0/no
Publication of NO910331L publication Critical patent/NO910331L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO91910331A 1990-01-29 1991-01-29 Rekombinant plasmid, fremgangsmaate til dets fremstilling og anvendelse av plasmidet i produksjonen av proteiner. NO910331L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4002521A DE4002521A1 (de) 1990-01-29 1990-01-29 Rekombinantes plasmid

Publications (2)

Publication Number Publication Date
NO910331D0 true NO910331D0 (no) 1991-01-29
NO910331L NO910331L (no) 1991-07-30

Family

ID=6398977

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91910331A NO910331L (no) 1990-01-29 1991-01-29 Rekombinant plasmid, fremgangsmaate til dets fremstilling og anvendelse av plasmidet i produksjonen av proteiner.

Country Status (8)

Country Link
EP (1) EP0443335A1 (no)
JP (1) JPH0515374A (no)
CA (1) CA2034564A1 (no)
CS (1) CS18991A2 (no)
DE (1) DE4002521A1 (no)
FI (1) FI910426A7 (no)
HU (1) HUT61331A (no)
NO (1) NO910331L (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1180157B1 (en) 1999-05-28 2012-11-28 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES A combined growth factor-deleted and thymidine kinase-deleted vaccinia virus vector
RU2180352C2 (ru) * 1999-11-24 2002-03-10 Государственный научный центр вирусологии и биотехнологии "Вектор" ФРАГМЕНТ ГЕНОМА ВИРУСА ОСПЫ КУР ШТАММА "К", СОДЕРЖАЩИЙ ГЕН ТИМИДИНКИНАЗЫ, РЕКОМБИНАНТНЫЕ ПЛАЗМИДНЫЕ ДНК pTK1FPV И pTK2FPV, СОДЕРЖАЩИЕ ЭТУ ПОСЛЕДОВАТЕЛЬНОСТЬ, И РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pINTFPV1, ОБЛАДАЮЩАЯ СПОСОБНОСТЬЮ ИНТЕГРИРОВАТЬСЯ В ГЕНОМ ВИРУСА ОСПЫ КУР

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2583429B1 (fr) * 1985-06-18 1989-11-03 Transgene Sa Vecteur d'expression de l'interferon u dans les cellules de mammifere, procede pour sa mise en oeuvre et produit obtenu et composition pharmaceutique contenant l'interferon u
WO1988002022A1 (en) * 1986-09-22 1988-03-24 Commonwealth Scientific And Industrial Research Or Recombinant poxviruses
ES2074422T3 (es) * 1987-03-20 1995-09-16 Immuno Ag Moleculas de adn y arn del subtipo accidental del virus fsma, polipeptidos, que son codificados por estas moleculas, y su uso.
GB8724885D0 (en) * 1987-10-23 1987-11-25 Binns M M Fowlpox virus promotors
EP0404835A4 (en) * 1988-03-18 1991-05-08 Us Health Novel recombinant vaccinia virus expression vectors and method of selecting same

Also Published As

Publication number Publication date
JPH0515374A (ja) 1993-01-26
FI910426A0 (fi) 1991-01-29
CS18991A2 (en) 1991-09-15
EP0443335A1 (en) 1991-08-28
HUT61331A (en) 1992-12-28
DE4002521A1 (de) 1991-08-01
CA2034564A1 (en) 1991-07-30
FI910426L (fi) 1991-07-30
HU910289D0 (en) 1991-08-28
NO910331L (no) 1991-07-30
FI910426A7 (fi) 1991-07-30

Similar Documents

Publication Publication Date Title
NO872729D0 (no) Cefalosporinhydrat og fremgangsmaate for dets fremstilling.
NO884795D0 (no) Rekombinant, humant immunoglobulin og fremgangsmaate for fremstilling av dette.
DK40484D0 (da) Polysaccharid/protein-konjugat,fremgangsmaade til fremstilling deraf og dets anvendelse i en vaccine
DK656189D0 (da) Stabiliseret sucralosekompleks, dets fremstilling og anvendelse
NO882356L (no) Naeringsmiddel og fremgangsmaate for dets fremstilling.
DE3882593D1 (de) Polypeptid und dessen herstellung.
NO912825L (no) Fremgangsmaate for fremstilling av kokonjugatvaksiner omfattende im munogent protein, hiv-beslektede peptider og anioniske grupper.
NO891334D0 (no) Supraledende material og fremgangsmaate for dets fremstilling.
NO880434D0 (no) Anestetisk preparat og fremgangsmaate for bruk derav.
NO883834D0 (no) Fremgangsmaate for fremstilling av nye hiv-proteiner og peptider.
NO891006D0 (no) Terapeutisk aktivt polypeptid og fremgangsmaate for dets fremstilling.
NO892869L (no) Heteropolysakkarider, fremgangsmaate for deres fremstilling og anvendelse.
DK375487D0 (da) Rekombinant-pseudorabiesvirus, dets anvendelse til proteinproduktion og saaledes fremstillede produkter
DK575787A (da) Rekombinant hcmv-afledt plasmid, dets fremstilling og anvendelse
NO894532D0 (no) Titandioksyd, fremgangsmaate for dets fremstilling og anvendelse derav.
ZA874430B (en) New polypeptides,their preparation and use
DK60088A (da) Rekombinant plasmid til ekspression af l-phenylalamin-ammoniaklyase og e.coli-stamme transformeret med samme
DK698188A (da) Peptider, deres fremstilling og anvendelse
NO902248D0 (no) Renininhiberende peptider, deres fremstilling og anvendelse i legemidler.
NO884324D0 (no) Fremgangsmaate til fremstilling av reninhemmende peptider og deres anvendelse.
NO910331D0 (no) Rekombinant plasmid, fremgangsmaate til dets fremstilling og anvendelse av plasmidet i produksjonen av proteiner.
DK587588A (da) Polypeptid, dets anvendelse og fremstilling
DK395989A (da) Praeparat til konservering af mikrobielt fordaervelige produkter, dets fremstiling og anvendelse
NO873481D0 (no) Peptidpreparat, fremgangsmaate for dets fremstilling og anvendelse derav.
DK587688A (da) Polypeptid, dets anvendelse og fremstilling